Evidence map›Paper›PMID 38334263›Full record

ArticleInflammatory bowel diseases2025

Vedolizumab Does Not Affect Antibody Secreting Cell Recruitment to the Lactating Mammary Gland of Mothers With Inflammatory Bowel Disease.

Josef Urrete, Taniya Mitra, Brigid S Boland, Kerri Bertrand, Christina Chambers, Jesús Rivera-Nieves

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inflammatory bowel diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Josef UrreteDivision of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Taniya MitraDivision of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Brigid S BolandDivision of Gastroenterology, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-5360-8816
Kerri BertrandDepartment of Pediatrics, Division of Environmental Science and Health, University of California San Diego, La Jolla, CA, USAñ.
Christina ChambersDepartment of Pediatrics, Division of Environmental Science and Health, University of California San Diego, La Jolla, CA, USAñ.
Jesús Rivera-NievesDivision of Gastroenterology, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-7887-7959
University of California San Diego · US

Funding

San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose TissuesR01DK131532 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RIVERA-NIEVES, JESUS, SMITH, DAVID MITCHELL · 2021 to 2025
$3.9M
Integrin αEβ7-dependent IgA transcytosis during homeostasis and IBDR01DK132242 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesus Rivera-Nieves · 2022 to 2026
$2.6M
Enhancing Mentoring of Diverse Early Career ResearchersK26DK138378 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesus Rivera-Nieves · 2023 to 2026
$448k
BLRD VA I01 BX005951NIDDK NIH HHS K26 DK138378NIDDK NIH HHS P30 DK120515NIDDK NIH HHS R01 DK131532NIDDK NIH HHS R01 DK132242NIDDK NIH HHS R01DK32242
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IgAintegrinslactationvedolizumab

Identifiers

PMID38334263
PMCPMC11700889
OpenAlexW4391682252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.